Skip to main content
. 2023 Aug 27;15(17):4285. doi: 10.3390/cancers15174285

Table 2.

Orbital exenteration and complications.

Variable n (%)
Orbital exenteration extent of resection n = 957
 Total 302 (31.6%)
 Extended 248 (26.0%)
 Subtotal 87 (9.0%)
 Unspecified 320 (33.4%)
Additional surgical interventions n = 146
 Maxillectomy 57 (39.0%)
 Lymph node resection 36 (24.7%)
 Ethmoidectomy 17 (11.6%)
 Craniotomy 14 (9.6%)
 Parotidectomy 5 (3.4%)
 Craniofacial resection 4 (2.7%)
 Enucleation 4 (2.7%)
 Rhinectomy 3 (2.1%)
 Tracheostomy 3 (2.1%)
 Posterior orbit sparing 2 (1.4%)
 Temporal bone resection 1 (0.7%)
Complications n = 168 *
 Sino-orbital/nasal fistula 40 (22.6%)
 Flap/graft/implant failure (loss/necrosis/atrophy) 30 (16.9%)
 Hyperostosis 23 (13.0%)
 Wound dehiscence/non-healing 19 (10.7%)
 CSF leak 15 (8.5%)
 Surgical site infection 12 (6.7%)
 Brain invasion 7 (4.0%)
 Hematoma 6 (3.3%)
 Socket hemorrhage 6 (3.3%)
 Socket draining 3 (1.7%)
 Transient facial weakness 3 (1.7%)
 Myocardial infarction 2 (1.1%)
 Stroke 2 (1.1%)
 Pulmonary infection 1 (0.6%)
 Delirium tremens 1 (0.6%)
 Eyelid fistula 1 (0.6%)
 Meningitis 1 (0.6%)
 Orbital abscess 1 (0.6%)
 Osteitis 1 (0.6%)
 Permanent facial weakness 1 (0.6%)
 Pulmonary edema 1 (0.6%)
 Trigeminal neuralgia 1 (0.6%)

Data are reported as frequencies and percentages. CSF, cerebrospinal fluid. * The total number of patients with complications does not sum up to the number of complications as many patients had multiple and complications.